Australian Therapeutic Goods Administration - Regulatory body for therapeutic goods in Australia
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| He Deep Sleep Formula | Martin & Pleasance Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha RenalCleanse | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| ENBREL etanercept (rch) 25 mg solution for injection cartridge | Pfizer Australia Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha GanoPoly A+ | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| He Focus & De-Stress Formula | Martin & Pleasance Pty Ltd | Medicine | Mar 23, 2021 | A |
| Deep Heat Low Odour Relief | Mentholatum Australasia Pty Ltd | Medicine | Mar 23, 2021 | A |
| SuperFeast I Am Gaia | JEMS Superfoods Pty Ltd trading as SuperFeast | Medicine | Mar 23, 2021 | A |
| ENBREL etanercept (rch) 50 mg solution for injection cartridge | Pfizer Australia Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha Tangulator | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha Heri-PAG | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha GanoPoly | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha Herbal PMT | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha BoneX | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| SuperFeast Cordyceps | JEMS Superfoods Pty Ltd trading as SuperFeast | Medicine | Mar 23, 2021 | A |
| Alpha GanoPoly B+ | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| ANAPEN 500 adrenaline (epinephrine) 500 micrograms/0.3 mL solution for injection pre-filled syringe (auto-injector) | Allergy Concepts Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha HeriPoly | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| ANAPEN JUNIOR 150 adrenaline (epinephrine) 150 micrograms/0.3 mL solution for injection pre-filled syringe (auto-injector) | Allergy Concepts Pty Ltd | Medicine | Mar 23, 2021 | A |
| Alpha FemoCare | Alpha Bio-Tech Aust Pty Ltd | Medicine | Mar 23, 2021 | A |
| ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial | Alexion Pharmaceuticals Australasia Pty Ltd | Medicine | Mar 23, 2021 | A |
